SCHEMBL29496334

SCHEMBL29496334

Brc1cccc2ccc(-c3ccncc3)nc12

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 5/20 0.53
AR P10275 3/20 0.53
NPC1 O15118 2/20 0.53
CYP1A2 P05177 1/20 0.53
CYP3A4 P08684 1/20 0.53
CYP2D6 P10635 1/20 0.53
CYP2C9 P11712 1/20 0.53
CYP2C19 P33261 1/20 0.53
BACE1 P56817 1/20 0.50
PARP1 P09874 2/20 0.41
KDM4E B2RXH2 5/20 0.37
SMN1; SMN2 Q16637 4/20 0.37
LMNA P02545 3/20 0.37
MAPT P10636 4/20 0.36
RXFP1 Q9HBX9 2/20 0.36
PPARG P37231 1/20 0.36
NCOA2 Q15596 1/20 0.36
NCOA1 Q15788 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
NCOA3 Q9Y6Q9 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28722905 1.00 RAB9A (0.53) RAB9AARNPC1CYP1A2CYP3A4
SCHEMBL15229057 0.85 PARP1 (0.54) RAB9AARNPC1CYP1A2CYP3A4
SCHEMBL29496195 0.83 CYP2A6 (0.51) RAB9AARNPC1CYP1A2CYP3A4
SCHEMBL28721995 0.83 CYP2A6 (0.51) RAB9AARNPC1CYP1A2CYP3A4
SCHEMBL29496146 0.82 BACE1 (0.50) RAB9AARNPC1CYP1A2CYP3A4
SCHEMBL28722848 0.82 BACE1 (0.50) RAB9AARNPC1CYP1A2CYP3A4
SCHEMBL14759591 0.81 AR (0.50) RAB9AARNPC1BACE1PARP1
SCHEMBL1034290 0.79 CYP3A4 (0.53) RAB9AARNPC1CYP1A2CYP3A4
SCHEMBL30590014 0.79 NPC1 (0.53) RAB9AARNPC1CYP1A2CYP3A4
SCHEMBL14428352 0.79 AR (0.53) RAB9AARNPC1CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114269730-A 5-heteroaryl-pyridin-2-amine compounds as neuropeptide FF receptor antagonists 多曼治疗学公司 2022-04-01 CN disclosed